Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial)
Product details
- Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial)
Company announcement
Eugia US LLC is voluntarily recalling lot number 3VM26026A of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial).
The recall, announced on November 6, 2026, is due to the presence of particulate matter identified as a glass particle inside the vial.
The product was shipped nationwide from September 2, 2026, through September 15, 2026.
No adverse events have been reported to date.
Risk:
There is a reasonable probability that use of product containing glass particulates can cause serious adverse health consequences such as blockage and clotting in blood vessels, which can cut off blood flow to vital organs, lead to a life-threatening blood clot in the lungs (pulmonary embolism) and cause permanent organ damage or death. Additionally, these particles may cause local vein irritation, inflammatory reaction, aggravation of preexisting infections, and allergic reactions. Greater susceptibility may exist in neonates, infants and patients with compromised organ function. To date, Eugia US LLC has not received any reports of adverse events related to this recall.
Impacted states: Nationwide
Products:
- Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial) (UPC code(s): 5515047101)
Contact
For more information, call (800) 505-9291 or email recall@qualanex.com.